Silverfin false false 31/12/2025 01/01/2025 31/12/2025 J Kohles 05/12/2023 D Lobban 05/12/2023 D C Thompson 15/08/2024 A C Wadsworth 06/11/2023 09 June 2026 no description of principal activity 15263646 2025-12-31 15263646 bus:Director1 2025-12-31 15263646 bus:Director2 2025-12-31 15263646 bus:Director3 2025-12-31 15263646 bus:Director4 2025-12-31 15263646 2024-12-31 15263646 core:CurrentFinancialInstruments 2025-12-31 15263646 core:CurrentFinancialInstruments 2024-12-31 15263646 core:ShareCapital 2025-12-31 15263646 core:ShareCapital 2024-12-31 15263646 core:RetainedEarningsAccumulatedLosses 2025-12-31 15263646 core:RetainedEarningsAccumulatedLosses 2024-12-31 15263646 core:ComputerEquipment 2024-12-31 15263646 core:ComputerEquipment 2025-12-31 15263646 core:ImmediateParent core:CurrentFinancialInstruments 2025-12-31 15263646 core:ImmediateParent core:CurrentFinancialInstruments 2024-12-31 15263646 2025-01-01 2025-12-31 15263646 bus:FilletedAccounts 2025-01-01 2025-12-31 15263646 bus:SmallEntities 2025-01-01 2025-12-31 15263646 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 15263646 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15263646 bus:Director1 2025-01-01 2025-12-31 15263646 bus:Director2 2025-01-01 2025-12-31 15263646 bus:Director3 2025-01-01 2025-12-31 15263646 bus:Director4 2025-01-01 2025-12-31 15263646 core:ComputerEquipment core:TopRangeValue 2025-01-01 2025-12-31 15263646 2023-11-06 2024-12-31 15263646 core:ComputerEquipment 2025-01-01 2025-12-31 15263646 1 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure

Company No: 15263646 (England and Wales)

AMICA SCIENTIFIC LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

AMICA SCIENTIFIC LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

AMICA SCIENTIFIC LIMITED

BALANCE SHEET

As at 31 December 2025
AMICA SCIENTIFIC LIMITED

BALANCE SHEET (continued)

As at 31 December 2025
Note 31.12.2025 31.12.2024
£ £
Fixed assets
Tangible assets 3 25,039 19,057
25,039 19,057
Current assets
Debtors 4 1,216,775 1,110,300
Cash at bank and in hand 469,520 14,354
1,686,295 1,124,654
Creditors: amounts falling due within one year 5 ( 1,571,975) ( 1,123,687)
Net current assets 114,320 967
Total assets less current liabilities 139,359 20,024
Provision for liabilities ( 4,391) ( 3,433)
Net assets 134,968 16,591
Capital and reserves
Called-up share capital 100 100
Profit and loss account 134,868 16,491
Total shareholder's funds 134,968 16,591

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Amica Scientific Limited (registered number: 15263646) were approved and authorised for issue by the Board of Directors on 09 June 2026. They were signed on its behalf by:

A C Wadsworth
Director
AMICA SCIENTIFIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
AMICA SCIENTIFIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

Amica Scientific Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Turner Heath, 103 Bollington Road, Bollington, SK10 5EL, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
* the amount of revenue can be measured reliably;
* it is probable that the Company will receive the consideration due under the contract;
* the stage of completion of the contract at the end of the reporting period can be measured reliably; and
* the costs incurred and the costs to complete the contract can be measured reliably.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

Year ended
31.12.2025
Period from
06.11.2023 to
31.12.2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 10 2

3. Tangible assets

Computer equipment Total
£ £
Cost
At 01 January 2025 21,161 21,161
Additions 14,539 14,539
At 31 December 2025 35,700 35,700
Accumulated depreciation
At 01 January 2025 2,104 2,104
Charge for the financial year 8,557 8,557
At 31 December 2025 10,661 10,661
Net book value
At 31 December 2025 25,039 25,039
At 31 December 2024 19,057 19,057

4. Debtors

31.12.2025 31.12.2024
£ £
Trade debtors 1,138,362 1,106,252
Other debtors 78,413 4,048
1,216,775 1,110,300

5. Creditors: amounts falling due within one year

31.12.2025 31.12.2024
£ £
Trade creditors 121,278 66,855
Amounts owed to Group undertakings 23,185 8,944
Amounts owed to Parent undertakings 399,138 399,138
Taxation and social security 122,358 70,764
Other creditors 906,016 577,986
1,571,975 1,123,687

6. Financial commitments

Pensions

The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

The pension cost charge represents contributions payable by the company to the funds and amounted to £44,572 (2024: £6,565). At the year end, there was an outstanding pension creditor amounted to £6,795 (2024: £991).

7. Ultimate controlling party

The immediate and ultimate parent company is Amica Scientific (Holdings) Limited, a company registered in England and Wales. There is no ultimate controlling party.